SG11201510736PA - THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS - Google Patents

THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Info

Publication number
SG11201510736PA
SG11201510736PA SG11201510736PA SG11201510736PA SG11201510736PA SG 11201510736P A SG11201510736P A SG 11201510736PA SG 11201510736P A SG11201510736P A SG 11201510736PA SG 11201510736P A SG11201510736P A SG 11201510736PA SG 11201510736P A SG11201510736P A SG 11201510736PA
Authority
SG
Singapore
Prior art keywords
thieno
treatment
viral infections
pyrimidines derivatives
pyrimidines
Prior art date
Application number
SG11201510736PA
Inventor
Gowan David Craig Mc
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP13178534 priority Critical
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Priority to PCT/EP2014/066219 priority patent/WO2015014815A1/en
Publication of SG11201510736PA publication Critical patent/SG11201510736PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
SG11201510736PA 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS SG11201510736PA (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP13178534 2013-07-30
PCT/EP2014/066219 WO2015014815A1 (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Publications (1)

Publication Number Publication Date
SG11201510736PA true SG11201510736PA (en) 2016-02-26

Family

ID=48874951

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201510736PA SG11201510736PA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
SG10201804306VA SG10201804306VA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201804306VA SG10201804306VA (en) 2013-07-30 2014-07-29 THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

Country Status (18)

Country Link
US (3) US9556199B2 (en)
EP (2) EP3404031A1 (en)
JP (1) JP6401788B2 (en)
KR (1) KR20160035583A (en)
CN (2) CN108912137A (en)
AU (2) AU2014298540B2 (en)
CA (1) CA2913691A1 (en)
CL (1) CL2015003767A1 (en)
DK (1) DK3027624T3 (en)
EA (1) EA201690303A1 (en)
ES (1) ES2701239T3 (en)
HK (1) HK1217707A1 (en)
IL (2) IL242872A (en)
MX (1) MX2016001464A (en)
PH (1) PH12015502797A1 (en)
SG (2) SG11201510736PA (en)
UA (1) UA117253C2 (en)
WO (1) WO2015014815A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113956C2 (en) 2011-04-08 2017-04-10 Pyrimidine derivatives for the treatment of viral infections
CA2850448C (en) 2011-11-09 2019-03-05 Janssen R&D Ireland Purine derivatives for the treatment of viral infections
EA201590215A1 (en) 2012-07-13 2015-06-30 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Macrocyclic purines for the treatment of viral infections
EA201590663A1 (en) 2012-10-10 2015-07-30 Янссен Сайенсиз Айрлэнд Юси PIRROLO [3,2-d] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISORDERS
CN105051018B (en) 2012-11-16 2019-09-20 爱尔兰詹森科学公司 For treating the 2- amino-quinazolines derivative of the heterocycle of viral infection being substituted
MX2015010856A (en) 2013-02-21 2015-12-01 Janssen Sciences Ireland Uc 2-aminopyrimidine derivatives for the treatment of viral infections.
BR112015024411A2 (en) 2013-03-29 2017-07-18 Janssen Sciences Ireland Uc macrocyclic desaza purinones for the treatment of viral infections
CN105377833B (en) 2013-05-24 2018-11-06 爱尔兰詹森科学公司 Pyridione derivatives for treating virus infection and other disease
CN105473592B (en) 2013-06-27 2018-10-26 爱尔兰詹森科学公司 Bi Kabing &#91 for treating virus infection and other diseases;3,2-d]Pyrimidine derivatives
SG11201510736PA (en) * 2013-07-30 2016-02-26 Janssen Sciences Ireland Uc THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
SG11201606876RA (en) 2015-03-04 2016-10-28 Gilead Sciences Inc Toll like receptor modulator compounds
AU2017318601A1 (en) 2016-09-02 2019-03-21 Gilead Sciences, Inc. Toll like receptor modulator compounds
WO2019084060A1 (en) 2017-10-24 2019-05-02 Silverback Therapeutics, Inc. Conjugates and methods of use thereof for selective delivery of immune-modulatory agents
WO2019118884A1 (en) 2017-12-15 2019-06-20 Silverback Therapeutics, Inc. Antibody construct-drug conjugate for the treatment of hepatitis
WO2019165374A1 (en) 2018-02-26 2019-08-29 Gilead Sciences, Inc. Substituted pyrrolizine compounds as hbv replication inhibitors
US20190309052A1 (en) 2018-04-05 2019-10-10 Gilead Sciences, Inc. Antibodies and fragments thereof that bind hepatitis b virus protein x
US20190322695A1 (en) 2018-04-06 2019-10-24 Institute of Organic Chemistry and Biochemistry, ASCR, V.V.I 2'3'-cyclic dinucleotides
US20190322696A1 (en) 2018-04-06 2019-10-24 Institute of Organic Chemistry and Biochemistry, ASCR, V.V.I 3'3'-cyclic dinucleotides
WO2019193533A1 (en) 2018-04-06 2019-10-10 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. 2'2'-cyclic dinucleotides
WO2019200247A1 (en) 2018-04-12 2019-10-17 Precision Biosciences, Inc. Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2610889B2 (en) 1987-09-03 1997-05-14 日本臓器製薬株式会社 A new cross-linked adenine derivatives
AU698419B2 (en) 1996-07-03 1998-10-29 Dainippon Sumitomo Pharma Co., Ltd. A novel purine derivative
AT340176T (en) 1996-08-28 2006-10-15 Pfizer Substituted 6,5-heterobicyclic derivatives
DE69717867D1 (en) 1996-10-04 2003-01-23 Kyorin Seiyaku Kk Pyrazolopyridylpyrazinon derivatives and a process for their production
AR012634A1 (en) 1997-05-02 2000-11-08 Sugen Inc Quinazoline-based compound, famaceutica composition comprising, method to synthesize, their use, methods of modulating the deserina / threonine protein kinase with said compound and function in vitro method for identifying compounds that modulate said function
US6339089B2 (en) * 1997-08-13 2002-01-15 Fujirebio Inc. Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
AU732361B2 (en) 1997-11-28 2001-04-26 Dainippon Sumitomo Pharma Co., Ltd. Novel heterocyclic compounds
TW572758B (en) 1997-12-22 2004-01-21 Sumitomo Pharma Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
KR20010041015A (en) 1998-02-17 2001-05-15 윌리엄 제이. 리플린 Anti-viral pyrimidine derivatives
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
JP4342007B2 (en) 1998-08-10 2009-10-14 住友化学株式会社 Quinazoline derivatives
JP4315300B2 (en) 1998-08-10 2009-08-19 住友化学株式会社 Novel quinazoline derivatives
AT267175T (en) 1998-08-27 2004-06-15 Sumitomo Pharma pyrimidine derivatives
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
US6503908B1 (en) 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds
WO2002088079A2 (en) 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
WO2003055890A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
TW200407143A (en) 2002-05-21 2004-05-16 Squibb Bristol Myers Co Pyrrolotriazinone compounds and their use to treat diseases
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
AU2003242252A1 (en) 2002-06-07 2003-12-22 Kyowa Hakko Kogyo Co., Ltd. Bicyclic pyrimidine derivatives
NZ539064A (en) 2002-09-27 2007-09-28 Dainippon Sumitomo Pharma Co Novel adenine compound and use thereof
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
WO2005007672A2 (en) 2003-06-20 2005-01-27 Coley Pharmaceutical Gmbh Small molecule toll-like receptor (tlr) antagonists
EP1667694B1 (en) 2003-09-05 2010-04-28 Anadys Pharmaceuticals, Inc. Tlr7 ligands for the treatment of hepatitis c
CN1938307B (en) 2004-03-26 2010-06-16 大日本住友制药株式会社 9-substituted 8-oxoadenine compound
WO2005092892A1 (en) 2004-03-26 2005-10-06 Dainippon Sumitomo Pharma Co., Ltd. 8-oxoadenine compound
WO2007084413A2 (en) 2004-07-14 2007-07-26 Ptc Therapeutics, Inc. Methods for treating hepatitis c
CN101035773B (en) 2004-08-10 2012-06-06 詹森药业有限公司 HIV inhibiting 1.2.4-triazin-6-one derivates
BRPI0517559A (en) 2004-11-09 2008-10-14 Hoffmann La Roche compound, process for its preparation, method for the therapeutic and / or prophylactic treatment of diseases that are modulated by ptb-1b inhibitors and use of the compounds
US7498409B2 (en) 2005-03-24 2009-03-03 Schering Corporation Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
WO2006117670A1 (en) 2005-05-04 2006-11-09 Pfizer Limited 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
TW200716631A (en) 2005-05-12 2007-05-01 Tibotec Pharm Ltd Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
US7994360B2 (en) 2005-05-16 2011-08-09 Xtl Biopharmaceuticals Ltd. Benzofuran compounds
JP4850911B2 (en) 2005-09-01 2012-01-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Diaminopyrimidines as P2X3 and P2X2 / 3 modulators
EP1939198A4 (en) 2005-09-22 2012-02-15 Dainippon Sumitomo Pharma Co Novel adenine compound
WO2007056208A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc. N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1970373A1 (en) 2005-12-02 2008-09-17 Mitsubishi Tanabe Pharma Corporation Alicyclic heterocyclic compound
JP2009528989A (en) 2006-02-17 2009-08-13 ファイザー・リミテッドPfizer Limited 3-Deazapurine derivatives as TLR7 modulators
US8673929B2 (en) 2006-07-20 2014-03-18 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
US9259426B2 (en) 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US9487533B2 (en) * 2006-12-07 2016-11-08 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and methods of use
CA2672250C (en) 2006-12-20 2013-04-30 Ian Stansfield Antiviral indoles
WO2008115319A2 (en) 2007-02-07 2008-09-25 Regents Of The University Of California Conjugates of synthetic tlr agonists and uses therefor
JP2008222557A (en) 2007-03-08 2008-09-25 Kotobuki Seiyaku Kk PYRROLO[3,2-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS EFFECTIVE COMPONENT
WO2008114008A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7 ) modulators
PE18872008A1 (en) 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co New adenine compound
JPWO2008114819A1 (en) 2007-03-20 2010-07-08 大日本住友製薬株式会社 New adenine compounds
AT518840T (en) 2007-05-22 2011-08-15 Boehringer Ingelheim Int Benzimidazolonchymasehemmer
BRPI0813952A2 (en) 2007-06-29 2017-05-09 Gilead Sciences Inc purine derivatives and their use as modulators and bell-like receptor 7
AU2008287421A1 (en) 2007-08-10 2009-02-19 Glaxosmithkline Llc Nitrogen containing bicyclic chemical entities for treating viral infections
EA017252B1 (en) 2007-08-28 2012-11-30 Айрм Ллк The 2-bifenilamino-4-aminopyrimidine derivatives as kinase inhibitors
WO2009030998A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Pyrimidine compounds as toll-like receptor (tlr) agonists
PE12362009A1 (en) 2007-11-22 2009-09-16 Astrazeneca Ab Pyrimidine derivatives as immunomodulators TLR7
US8524716B2 (en) 2007-12-24 2013-09-03 Janssen R&D Ireland Macrocyclic indoles as hepatitis C virus inhibitors
US20090202626A1 (en) 2008-02-07 2009-08-13 Carson Dennis A Treatment of bladder diseases with a tlr7 activator
CN102014911A (en) 2008-04-28 2011-04-13 默沙东公司 HCV NS3 protease inhibitors
US8946239B2 (en) 2008-07-10 2015-02-03 Duquesne University Of The Holy Spirit Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
UY31982A (en) 2008-07-16 2010-02-26 Boehringer Ingelheim Int You derived from 1,2-dihydropyridin-3-N-substituted carboxamides
WO2010133885A1 (en) 2009-05-21 2010-11-25 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
TWI468402B (en) 2009-07-31 2015-01-11 Squibb Bristol Myers Co Compounds for the reduction of β-amyloid production
US8637525B2 (en) 2009-07-31 2014-01-28 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
CN102666537A (en) 2009-10-20 2012-09-12 艾格尔生物制药股份有限公司 Azaindazoles to treat flaviviridae virus infection
SG10201406813RA (en) 2009-10-22 2014-11-27 Gilead Sciences Inc Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
KR101094446B1 (en) * 2009-11-19 2011-12-15 한국과학기술연구원 2,4,7-Substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
JP2013032290A (en) 2009-11-20 2013-02-14 Dainippon Sumitomo Pharma Co Ltd Novel fused pyrimidine derivative
DE102010040233A1 (en) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclic aza heterocycles and their use
WO2012066335A1 (en) 2010-11-19 2012-05-24 Astrazeneca Ab Phenol compounds als toll -like receptor 7 agonists
WO2012067269A1 (en) 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease
JP2014515740A (en) * 2011-03-30 2014-07-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Anticoagulant antidote
UA113956C2 (en) 2011-04-08 2017-04-10 Pyrimidine derivatives for the treatment of viral infections
US8916575B2 (en) 2011-05-18 2014-12-23 Janssen R&D Ireland Quinazoline derivatives for the treatment of viral infections and further diseases
CA2850448C (en) 2011-11-09 2019-03-05 Janssen R&D Ireland Purine derivatives for the treatment of viral infections
AU2013218072B2 (en) 2012-02-08 2017-08-31 Janssen Sciences Ireland Uc Piperidino-pyrimidine derivatives for the treatment of viral infections
EP2841428B1 (en) 2012-04-24 2018-08-22 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors
EA201590215A1 (en) 2012-07-13 2015-06-30 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Macrocyclic purines for the treatment of viral infections
CN104781239B (en) 2012-08-10 2019-03-01 爱尔兰詹森科学公司 For treating the alkyl derivative of virus infection and other disease
EP2712866A1 (en) 2012-10-01 2014-04-02 Centre National de la Recherche Scientifique (CNRS) 1,2,4-triazine derivatives for the treatment of viral infections
BR112015007366A2 (en) 2012-10-05 2017-07-04 Janssen Sciences Ireland Uc acylaminopyrimidine derivatives for the treatment of viral infections and other diseases
EA201590663A1 (en) 2012-10-10 2015-07-30 Янссен Сайенсиз Айрлэнд Юси PIRROLO [3,2-d] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISORDERS
CN105051018B (en) 2012-11-16 2019-09-20 爱尔兰詹森科学公司 For treating the 2- amino-quinazolines derivative of the heterocycle of viral infection being substituted
MX2015010856A (en) 2013-02-21 2015-12-01 Janssen Sciences Ireland Uc 2-aminopyrimidine derivatives for the treatment of viral infections.
BR112015024411A2 (en) 2013-03-29 2017-07-18 Janssen Sciences Ireland Uc macrocyclic desaza purinones for the treatment of viral infections
SG11201510736PA (en) * 2013-07-30 2016-02-26 Janssen Sciences Ireland Uc THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
EP3166938A4 (en) 2014-07-11 2018-01-17 Northwestern University 2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

Also Published As

Publication number Publication date
US20190330227A1 (en) 2019-10-31
CN108912137A (en) 2018-11-30
EP3027624B1 (en) 2018-09-12
SG10201804306VA (en) 2018-06-28
PH12015502797A1 (en) 2016-03-14
IL242872A (en) 2019-06-30
MX2016001464A (en) 2016-06-02
AU2014298540A1 (en) 2015-12-17
US9556199B2 (en) 2017-01-31
UA117253C2 (en) 2018-07-10
US10316043B2 (en) 2019-06-11
EP3404031A1 (en) 2018-11-21
US20170298079A1 (en) 2017-10-19
AU2018256591A1 (en) 2018-11-22
CN105492446A (en) 2016-04-13
JP2016525148A (en) 2016-08-22
IL266897D0 (en) 2019-07-31
CN105492446B (en) 2018-08-03
AU2014298540B2 (en) 2018-08-09
ES2701239T3 (en) 2019-02-21
EA201690303A1 (en) 2016-06-30
HK1217707A1 (en) 2017-01-20
EP3027624A1 (en) 2016-06-08
JP6401788B2 (en) 2018-10-10
CL2015003767A1 (en) 2016-07-08
DK3027624T3 (en) 2019-01-07
WO2015014815A1 (en) 2015-02-05
KR20160035583A (en) 2016-03-31
CA2913691A1 (en) 2015-02-05
US20160168164A1 (en) 2016-06-16
IL242872D0 (en) 2016-02-01

Similar Documents

Publication Publication Date Title
HRP20181544T1 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
AU2013328732A8 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
JO3314B1 (en) Novel Amino Pyrimidine Derivatives
PT2997019T (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
AU2014331863A1 (en) Substituted nucleosides, nucleotides and analogs thereof
EP3055319A4 (en) Substituted nucleosides, nucleotides and analogs thereof
RS57222B1 (en) Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
IL241110D0 (en) N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
EP3013340A4 (en) Substituted nucleosides, nucleotides and analogs thereof
BR112015002524A2 (en) alkylpyrimidine derivatives for the treatment of viral infections and other diseases.
HRP20181464T1 (en) Pyrimidine derivatives for the treatment of viral infections
SG11201503042QA (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
ZA201405820B (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
IL239859D0 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
RU2016107721A (en) Thieno [2,3-c] piranes derivatives as cftr modulators
EP3024827A4 (en) Substituted quinazolin-4-one derivatives
AU2018256591A1 (en) Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
ZA201503470B (en) Pyrimidine-2,4-diamine derivatives for treatment of cancer
IL232046A (en) Purine derivatives for use in the treatment of viral infections
ZA201500186B (en) Macrocyclic purines for the treatment of viral infections
SG11201505309TA (en) Benzylamine derivatives
EP2991729B8 (en) Systems for the treatment of eye conditions
RU2015129560A (en) Mannose derivatives for the treatment of bacterial infections
DK2903967T3 (en) Acylaminopyrimidine derivatives for treating virus infections and additional diseases
ZA201601737B (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof